Evidence map›Paper›PMID 24998259›Full record

ArticleBMC structural biology2014

Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3.

Catherine N Leettola, Mary Jane Knight, Duilio Cascio, Sigrid Hoffman, James U Bowie

Open access · hybridAbstract read
In one paragraph

Article in BMC structural biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genes · 2024
    Article
  6. Review
  7. TheBiomedicines · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Structural insights into SAM domain-mediated tankyrase oligomerization.Protein science : a publication of the Protein Society · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Catherine N Leettola
Mary Jane Knight
Duilio Cascio
Sigrid Hoffman
James U BowieDepartment of Chemistry and Biochemistry, UCLA-DOE Institute of Genomics and Proteomics, Molecular Biology Institute, University of California, Los Angeles, Boyer Hall 611 Charles E, Young Dr, E, Los Angeles, California 90095-1570, USA. bowie@mbi.ucla.edu.
University of California, Los Angeles · USUniversity Medical Centre Mannheim · DE

Funding

UCLA NIGMS T32 Program AssessmentT32GM007185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORRES, JORGE · 1985 to 2020
$21.7M
Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
A SAM domain network in Polycystic Kidney DiseaseR01DK100482 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BOWIE, JAMES U · 2014 to 2017
$1.1M
NIDDK NIH HHS 5R01DK100482NIDDK NIH HHS R01 DK100482NIGMS NIH HHS GM007185NIGMS NIH HHS P41GM103403NIGMS NIH HHS T32 GM007185
6 · The paper itself

Abstract

backgroundAutosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disorder leading to end-stage renal failure in humans. In the PKD/Mhm(cy/+) rat model of ADPKD, the point mutation R823W in the sterile alpha motif (SAM) domain of the protein ANKS6 is responsible for disease. SAM domains are known protein-protein interaction domains, capable of binding each other to form polymers and heterodimers. Despite its physiological importance, little is known about the function of ANKS6 and how the R823W point mutation leads to PKD. Recent work has revealed that ANKS6 interacts with a related protein called ANKS3. Both ANKS6 and ANKS3 have a similar domain structure, with ankyrin repeats at the N-terminus and a SAM domain at the C-terminus.

resultsThe SAM domain of ANKS3 is identified as a direct binding partner of the ANKS6 SAM domain. We find that ANKS3-SAM polymerizes and ANKS6-SAM can bind to one end of the polymer. We present crystal structures of both the ANKS3-SAM polymer and the ANKS3-SAM/ANKS6-SAM complex, revealing the molecular details of their association. We also learn how the R823W mutation disrupts ANKS6 function by dramatically destabilizing the SAM domain such that the interaction with ANKS3-SAM is lost.

conclusionsANKS3 is a direct interacting partner of ANKS6. By structurally and biochemically characterizing the interaction between the ANKS3 and ANKS6 SAM domains, our work provides a basis for future investigation of how the interaction between these proteins mediates kidney function.

Indexed as

Ankyrin RepeatAmino Acid SequenceAnimalsBinding SitesCarrier ProteinsCircular DichroismHumansModels, MolecularMutationNuclear ProteinsProtein ConformationProtein Structure, SecondaryProtein Structure, TertiaryRatsSurface Plasmon ResonanceANKS3 protein, humanANKS3 protein, ratANKS6 protein, humanCarrier ProteinsNuclear Proteins

Identifiers

PMID24998259
PMCPMC4105859
OpenAlexW2003929435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.